Jerzy Kupiec-Weglinski Selected Research

Endothelin Receptor Antagonists

12/2008

Tezosentan, a novel endothelin receptor antagonist, markedly reduces rat hepatic ischemia and reperfusion injury in three different models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jerzy Kupiec-Weglinski Research Topics

Disease

5	Reperfusion Injury 01/2022 - 01/2005
3	Ischemia 04/2012 - 01/2005
1	Necrosis 01/2022
1	Inflammation (Inflammations) 01/2017
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 12/2016
1	Neoplasms (Cancer) 08/2005
1	Herpes Simplex 08/2005

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2005
3	LigandsIBA 07/2011 - 01/2005
2	P-SelectinIBA 07/2011 - 01/2005
2	Glycoproteins (Glycoprotein)IBA 07/2011 - 01/2005
1	ChemokinesIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Pattern Recognition ReceptorsIBA 12/2016
1	Oxygen (Dioxygen)IBA 04/2012
1	Immunoglobulin G (IgG)IBA 07/2011
1	tezosentanIBA 12/2008
1	Endothelins (Endothelin)IBA 12/2008
1	Endothelin Receptor AntagonistsIBA 12/2008
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 08/2005
1	Thymidine KinaseIBA 08/2005
1	Immunoglobulins (Immunoglobulin)IBA 01/2005

Therapy/Procedure

2	Transplantation 04/2012 - 01/2005
1	Liver Transplantation 01/2022
1	Resuscitation 04/2012
1	Warm Ischemia 04/2012
1	Therapeutics 08/2005